Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dexcom
MedTech
Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD
Three diabetes tech companies made the case in Barcelona for their CGMs and insulin pumps as they look to expand their reach in Type 2 diabetes.
Conor Hale
Mar 12, 2026 1:07pm
Dexcom CEO outlines plan to stop a repeat of G7 supply shortage
Jan 13, 2026 8:10am
FDA clears Dexcom's basal dosing software for Type 2 diabetes
Nov 19, 2025 9:45am
Dexcom hit by FDA Class I recall for its CGM system app
Nov 5, 2025 8:45am
Dexcom CEO goes on leave while Insulet taps new CFO
Sep 17, 2025 12:15pm
Dexcom CEO Kevin Sayer to pass torch to COO Jake Leach
Jul 31, 2025 11:00am
